PL2646035T3 - Proleki 6-cykloheksylo-1-hydroksy-4-metylopirydyn-2(1h)-onu i ich pochodne - Google Patents

Proleki 6-cykloheksylo-1-hydroksy-4-metylopirydyn-2(1h)-onu i ich pochodne

Info

Publication number
PL2646035T3
PL2646035T3 PL11845102T PL11845102T PL2646035T3 PL 2646035 T3 PL2646035 T3 PL 2646035T3 PL 11845102 T PL11845102 T PL 11845102T PL 11845102 T PL11845102 T PL 11845102T PL 2646035 T3 PL2646035 T3 PL 2646035T3
Authority
PL
Poland
Prior art keywords
methylpyridin
prodrugs
cyclohexyl
hydroxy
derivatives
Prior art date
Application number
PL11845102T
Other languages
English (en)
Inventor
Mehmet Tanol
Scott J Weir
Original Assignee
Univ Kansas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kansas filed Critical Univ Kansas
Publication of PL2646035T3 publication Critical patent/PL2646035T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/094Esters of phosphoric acids with arylalkanols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/11Esters of phosphoric acids with hydroxyalkyl compounds without further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/59Hydrogenated pyridine rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6596Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having atoms other than oxygen, sulfur, selenium, tellurium, nitrogen or phosphorus as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL11845102T 2010-12-02 2011-12-02 Proleki 6-cykloheksylo-1-hydroksy-4-metylopirydyn-2(1h)-onu i ich pochodne PL2646035T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41921810P 2010-12-02 2010-12-02
EP11845102.0A EP2646035B1 (en) 2010-12-02 2011-12-02 Prodrugs of 6-cyclohexyl-1-hydroxy-4- methylpyridin-2(1h)-one and derivatives thereof
PCT/US2011/063070 WO2012075396A2 (en) 2010-12-02 2011-12-02 Prodrugs of 6-cyclohexyl-1-hydroxy-4- methylpyridin-2(1h)-one and derivatives thereof

Publications (1)

Publication Number Publication Date
PL2646035T3 true PL2646035T3 (pl) 2016-08-31

Family

ID=46162781

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11845102T PL2646035T3 (pl) 2010-12-02 2011-12-02 Proleki 6-cykloheksylo-1-hydroksy-4-metylopirydyn-2(1h)-onu i ich pochodne

Country Status (10)

Country Link
US (3) US8609637B2 (pl)
EP (1) EP2646035B1 (pl)
JP (1) JP5853028B2 (pl)
DK (1) DK2646035T3 (pl)
ES (1) ES2573116T3 (pl)
HR (1) HRP20160478T1 (pl)
HU (1) HUE028411T2 (pl)
PL (1) PL2646035T3 (pl)
RS (1) RS54766B1 (pl)
WO (1) WO2012075396A2 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5853028B2 (ja) * 2010-12-02 2016-02-09 カンザス大学 6−シクロヘキシル−1−ヒドロキシ−4−メチルピリジン−2(1h)−オンのプロドラッグおよびその誘導体
US8426450B1 (en) * 2011-11-29 2013-04-23 Helsinn Healthcare Sa Substituted 4-phenyl pyridines having anti-emetic effect
CN116687941A (zh) * 2014-11-11 2023-09-05 堪萨斯大学 用环吡酮、环吡酮胺或环吡酮前药治疗膀胱癌的方法
KR101761830B1 (ko) 2015-10-21 2017-07-26 주식회사 엘지화학 리간드 화합물, 올레핀 올리고머화용 촉매계, 및 이를 이용한 올레핀 올리고머화 방법
CN107987103A (zh) * 2017-12-14 2018-05-04 朱恒军 磷酸三甲酯的制备方法
CN108003188A (zh) * 2017-12-25 2018-05-08 长春吉大天元化学技术股份有限公司 一种烷基磷酸酯类化合物的新型纯化方法
CN112351970A (zh) * 2018-05-30 2021-02-09 科莱恩国际有限公司 2-羟基吡啶-1-氧化物或其衍生物的形成方法
EP4193989A1 (en) 2021-12-09 2023-06-14 Atlas Molecular Pharma, S.L. A formulation for an effective oral administration of ciclopirox with no adversal gasterointestinal toxicity
KR102800868B1 (ko) * 2021-12-31 2025-04-29 주식회사 삼양케이씨아이 치환된 1-하이드록시-2-피리돈 화합물의 신규한 제조 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19639818A1 (de) * 1996-09-27 1998-04-02 Hoechst Ag Verwendung von 1-Hydroxy-2-pyridonen zur Behandlung der Seborrhoischen Dermatitis
US20040039030A1 (en) * 1996-09-27 2004-02-26 Hoechst Akeengesellschaft Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
AU754965B2 (en) * 1997-12-31 2002-11-28 University Of Kansas, The Water soluble prodrugs of tertiary amine containing drugs and methods of making thereof
US6204257B1 (en) * 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
JP2005537244A (ja) * 2002-06-28 2005-12-08 ナステック・ファーマシューティカル・カンパニー・インコーポレーテッド 療法化合物の粘膜搬送を増進させるための、上皮接合部接着分子の生理機能を調節する組成物および方法
US7605138B2 (en) * 2002-07-03 2009-10-20 Coley Pharmaceutical Group, Inc. Nucleic acid compositions for stimulating immune responses
US20060272103A1 (en) * 2005-03-18 2006-12-07 L'oreal Compositions comprising KAP polypeptides
US20110212176A1 (en) * 2008-10-31 2011-09-01 University Health Network Ciclopirox and cytarabine for the treatment of leukemic disorders
JP5853028B2 (ja) * 2010-12-02 2016-02-09 カンザス大学 6−シクロヘキシル−1−ヒドロキシ−4−メチルピリジン−2(1h)−オンのプロドラッグおよびその誘導体

Also Published As

Publication number Publication date
US8609637B2 (en) 2013-12-17
WO2012075396A2 (en) 2012-06-07
JP5853028B2 (ja) 2016-02-09
JP2013544289A (ja) 2013-12-12
US9243014B2 (en) 2016-01-26
US20120142637A1 (en) 2012-06-07
US9545413B2 (en) 2017-01-17
HRP20160478T1 (hr) 2016-07-01
HUE028411T2 (en) 2016-12-28
EP2646035A4 (en) 2014-05-07
US20160095870A1 (en) 2016-04-07
RS54766B1 (sr) 2016-10-31
US20150111858A1 (en) 2015-04-23
EP2646035A2 (en) 2013-10-09
EP2646035B1 (en) 2016-03-09
ES2573116T3 (es) 2016-06-06
WO2012075396A3 (en) 2012-12-27
DK2646035T3 (en) 2016-05-30

Similar Documents

Publication Publication Date Title
IL237581B (en) Derivatives of 6-oxo-pyrazinopyrrolopyrimidines
IL217745A0 (en) Antiviral compounds and methods of making and using thereof
ZA201206227B (en) Forms of rifaximin and uses thereof
IL221132A0 (en) Derivatives of betulin
ZA201300193B (en) Formulations of rifaximin and uses thereof
IL222227A0 (en) Pyrazol - 4 - heterocyclyl-carboxamide compounds and methods of use
PL2646035T3 (pl) Proleki 6-cykloheksylo-1-hydroksy-4-metylopirydyn-2(1h)-onu i ich pochodne
IL225869A (en) Colentrazine derivatives and methods for their use
IL236830A0 (en) Diazahomoredene derivatives and methods of using them
ZA201208770B (en) New forms of rifaximin and uses thereof
IL227642A0 (en) Rifaximin formulations and their uses
ZA201203076B (en) Spirolactam derivatives and uses of same
SG2014013460A (en) Monohydrate of an azaadamantane derivative
ZA201209666B (en) Salts and polymorhs of dexrabeprazole
HUE055712T2 (hu) Hop savak és származékaik elõállítása
IL229968A0 (en) Tetrazolyloxy derivatives and methods for their production
IL219935A0 (en) Small pyrimidine derivatives and methods of use thereof
EP2601200A4 (en) PREPARATION FROM PRASUGRELHYDROCHLORIDE
PL2407155T3 (pl) Formulacje inekalcytolu
ZA201307230B (en) Prodrugs of d-gamma-glutamyl-d-tryptophan and d-gamma-glutamyl-l-tryptophan
GB201301307D0 (en) Crystalline form of prulifloxacin and processes for its preparation
IL243319A0 (en) Intermediates of teroarylpiperidine and piperazine derivatives
GB201021893D0 (en) Prodrugs of non-opioids and uses thereof
GB201111376D0 (en) Prodrugs of opioids and uses thereof
GB201112080D0 (en) Prodrugs of opioids and uses thereof